Pulmatrix (PULM) Gains from Sales and Divestitures (2016 - 2024)
Pulmatrix (PULM) recorded Gains from Sales and Divestitures of -$2.62 million in FY2024, compared with -$8,000 in FY2023.
Analysis
Pulmatrix (PULM) Gains from Sales and Divestitures (2016 - 2024) Analysis & Trends
Starting with FY2014, Pulmatrix's Gains from Sales and Divestitures history includes 6 years.
- The FY2024 figure is the lowest annual Gains from Sales and Divestitures in data going back to FY2014.
- Per Business Quant data, PULM's Gains from Sales and Divestitures was -$8,000 in FY2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Pulmatrix | 5.81 Mn | 5.81 Mn | - |
API Access
Pulmatrix Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PULM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "PULM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=PULM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();